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Abstract 
We describe two brothers with lower facial weakness, highly arched palate, scaphocephaly due 
to synostosis of the sagittal and metopic sutures, axial hypotonia, proximal muscle weakness, and 
mild scoliosis. The muscle MRI of the younger sibling revealed a selective pattern of atrophy of 
the gluteus maximus, adductor magnus and soleus muscles. Muscle biopsy of the younger sibling 
revealed myofibres with internalized nuclei, myofibrillar disarray, and “corona” fibres. Both 
affected siblings were found to be compound heterozygous for c.3425G>A (p.Arg1142Gln) and 
c.1123T>C (p.Cys375Arg) mutations in SCN4A on exome sequencing, and the parents were 
confirmed carriers of one of the mutations. Electrophysiological characterization of the 
mutations revealed the Cys375Arg confers full and Arg1142Gln mild partial loss-of-function.  
Loss of function of the Nav1.4 channel leads to a decrement of the action potential and 
subsequent reduction of muscle contraction. The unusual muscle biopsy features suggest a more 
complex pathomechanism, and broaden the phenotype associated with SCN4A mutations.  
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1. Introduction 
The sodium channel is essential for generation and propagation of action potentials [1]. In 
skeletal muscle, the predominant isoform, Nav1.4, is encoded by SCN4A and is responsible for 
>90% of the sodium current in muscle fibres [2]. SCN4A mutations yield a broad range of 
phenotypes depending on the underlying pathophysiology. Dominant mutations usually lead to a 
gain of function of the Nav1.4 sodium channel, resulting in congenital myotonia or periodic 
paralysis, collectively known as sodium channelopathies [3].  These mutations in SCN4A can 
result in sustained muscle contraction, causing myotonia, or a prolonged refractory state with fast 
inactivation of the channel, yielding a periodic paralysis phenotype [4, 5]. In rare cases recessive 
loss of function SCN4A mutations have been shown to cause a congenital myasthenic syndrome 
[3, 6]. Recently, Zaharieva et al. (2016) described a spectrum of phenotypes ranging from severe 
foetal hypokinesia to congenital myopathy, associated with loss of function of the channel due to 
recessive mutations in SCN4A in 11 patients from six unrelated families. Muscle biopsies of their 
patients were non-specific and there were no distinct features indicative of a specific subtype of 
congenital myopathy. Muscle MRI in a subset of these patients revealed a consistent pattern, 
with predominant involvement of the gluteus maximus, adductor magnus, sartorius, and soleus 
muscles [7]. We describe two siblings with loss of function of the Nav1.4 channel due to 
compound heterozygous mutations in SCNA4 and features of congenital myopathy with “corona” 
fibres on muscle biopsy. 
2. Case presentation 
Two siblings, aged 21 (Sibling 1) and 18 (Sibling 2), were born to non-consanguineous parents 
of East Indian background (Fig. 1). Written informed consent was obtained from both subjects to 
participate in this study. 
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Sibling 1 was born at term following a normal pregnancy. Hypotonia was noted at birth, but he 
achieved all motor milestones on time. He started walking at 14 months of age, but his parents 
noticed that he tended to fall and trip often and he had weakness of the proximal muscles of the 
lower limbs. He had motor difficulties which impaired daily living. There was no history of 
fluctuating or fatigable weakness, seizures, swallowing difficulties, myotonia, cardiac symptoms, 
rhabdomyolysis or migraine.   
On physical exam, he had a highly arched palate, distal joint hypermobility, bilateral 
gynecomastia (surgically corrected), mild scoliosis and pectus excavatum. (Fig.1A) There was 
no scapular winging or impairment of extraocular movements. He had mild bilateral ptosis, 
lower facial muscle weakness, and pseudohypertrophy of both calves. (Fig. 1B) Neck strength 
was normal; he had weakness of the deltoids and biceps in the upper limbs. Evaluation of lower 
extremity strength revealed weakness in all proximal muscles except for hip abductors, and he 
had mild weakness of the distal muscles. Reflexes were normal throughout. He had a waddling 
gait and difficulty walking on his heels.  
The younger sibling (Sibling 2) had similar symptoms but with more pronounced weakness. 
Also, he had a longstanding history of recurrent episodes of flaccid paralysis after fever.  Cranial 
CT for Sibling 1 and skeletal survey for Sibling 2 revealed scaphocephaly due to synostosis of 
the sagittal and metopic sutures (Fig.1E,F) 
CK levels in both siblings were mildly elevated; 524 and 605 IU/L respectively for Sibling 1 and 
2. Muscle MRI for Sibling 2 revealed a pattern identical to the one described by Zaharieva et al., 
with selective involvement of gluteus maximus, sartorius, adductor magnus and soleus muscles 
(Fig.1G-L) [7]. 
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3. Methods 
3.1 Molecular Genetics 
Exome capture was carried out using the Agilent SureSelect Clinical Research Exome target 
enrichment kit from 3µg of genomic DNA using the Bravo Automated Liquid Handling Platform 
(Agilent Technologies). Sequencing was carried out on Illumina HiSeq2500 in rapid mode and 
V1 sequencing chemistry following the manufacturer’s instructions and sequenced to a mean 
depth of coverage of 135X. Base calling was performed using CASAVA v1.8.2 and reads were 
mapped to the hg19 reference sequence with decoy using BWA-MEM v0.7.8. Duplicate reads 
were removed using MarkDuplicates from Picard v1.108. Local read realignment around indels, 
base quality score recalibration, and variant calling with UnifiedGenotyper were accomplished 
using GATK v2.8.1. SNP calls were subjected to variant quality score recalibration and hard-
filters by variant call annotations QualByDepth (QD >=2.0), Phred-scaled p-value using Fisher’s 
exact test to detect strand bias (FS <= 60.0), RMS Mapping quality (MQ >=40.0), Mapping 
Quality RankSum (MQRS >= 12.5), Haplotype Score (HS<=13.0), and ReadPosRankSum 
(ReadPosRankSum >= -8.0). Indel calls were hard-filtered by variant call annotations 
QualByDepth (QD >= 2.0), ReadPosRankSumTest (ReadPosRankSum < -20.0), and Phred-
scaled p-value using Fisher’s exact test to detect strand bias (FS <= 200.0). Resulting variant 
calls were annotated with population frequency information, variant effect on protein, and in 
silico prediction program using a custom pipeline based on ANNOVAR (downloaded on 14-07-
2014) and SnpEff 4.0. 
3.2 Mutagenesis, HEK293 cell transfection 
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The expression clone carrying the human SCN4A insert was a gift from SC Cannon (University 
of Texas Southwestern Medical Center, Dallas, USA). Site directed mutagenesis was performed 
using the QuikChange kit (Agilent technologies) and successful mutagenesis was confirmed by 
sequencing the entire insert. HEK293 cells were transfected with 0.5 μg of wild type or mutant 
plasmid and 50 ng of plasmid coding for cop-GFP using Lipofectamine 2000 (Thermofisher) in a 
1.9 cm2 well.  
3.3 Patch clamp studies 
HEK293 cells with fluorescence were voltage clamped 48-72 hrs following transfection using 
Axopatch 200B, Digidata 1550A and pCLAMP  software (all Axon instruments) at room 
temperature. Extracellular solution was (in mM): NaCl 145, KCl 4, MgCl2 1, CaCl2 2, HEPES 
10, pH 7.4 (NaOH). Patch electrodes were filled with pipette solution (in mM): NaCl 5, CsCl 
145, EGTA 10, HEPES 10, pH 7.3 (CsOH). Junction potential was estimated -4.4 mV and not 
corrected for. The series resistance error was less than 5 mV. Currents were low-pass filtered at 5 
kHz and sampled at 50 kHz. Data was analyzed and presented using pCLAMP, Origin 
(OriginLab) and Excel (Microsoft) software. The voltage protocols are described in the figure 
legend. Current- and conductance-voltage relationships were fitted with the Boltzmann equation: 
G = (A + (B − A))/(1 + exp((V1/2 − V)/VSlope)), where A and B are the maximum and minimum 
conductance, V1/2 is the voltage where conductance is (A-B)/2 and VSlope is the slope factor. The 
time course data were fitted with single or double exponential functions. Statistical comparisons 
were performed using an un-paired, two-tailed Student’s t test. 
4. Results 
4.1 Muscle Biopsy 
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H&E staining of the right quadriceps from Sibling 2 revealed significant fatty replacement and 
fibrosis involving the perimysium with no inflammation or vasculitis. The muscle fibres showed 
mild variation in fibre size, and the majority of muscle fibres had multiple internalized nuclei. 
These nuclei showed a distinctive arrangement, being located away from the sarcolemma, and 
surrounding a central core-like structure. The nuclei have the appearance of a "crown", or 
“corona”, with the central area of core-like disorganization within the fibres representing a head 
of hair, surrounded by a crown of nuclei.  (Fig. 2A).  
Frozen section slides stained with ATPase (4.2 and 9.6) showed predominance of type I fibers. 
There was no evidence of grouping, or selective fibre type atrophy or degeneration. Areas of 
clearly defined central pallor were observed in both types of fibers (Fig. 2D). Further stains for 
oxidative enzymes (NADH-TR, COX and SDH) highlighted the absence of oxidative enzyme 
activity at the center of these myofibres (Fig. 2B). There were no enzyme aggregates or COX-
deficient fibres.  Gomori trichrome staining showed no evidence of ragged red fibres; however 
the cores of the affected fibres were highlighted as intense dark green aggregates (Fig. 2C). PAS 
and Oil red O stains were normal. Desmin staining revealed desmin-positive aggregates and 
preferential labeling of the “crown” with the antibody (Fig. 2E).   
Electron microscopy studies showed myofibrillar disarray predominantly located at the centre of 
affected fibres and rarely peripherally located. These core-like structures are encircled/rimmed 
by multiple nuclei within a single myofibre. Mitochondria and other organelles were seen 
clustering toward the periphery of the fibres, beyond the nuclear rim (Fig. 2F). Other fibres 
showed only myofibrillar disarray. The sarcolemma was preserved with no evidence of 
duplication, and there were no nemaline rods or deposits. The mitochondria showed normal 
subsarcolemmal peripheral aggregation, with preserved shape and size. No abnormal glycogen 
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accumulation was seen. The blood vessels were normal with no evidence of tubuloreticular 
inclusions.  
4.2 Exome sequencing  
Both affected siblings were found to be compound heterozygous for c.3425G>A (p.Arg1142Gln) 
and c.1123T>C (p.Cys375Arg) mutations in SCN4A (NM_000334.4) on exome sequencing, and 
the parents were confirmed carriers (Fig.1M-N). All exons of DNM2 and MTM1 were well 
covered, with each base pair of the coding regions sequenced to at least 20X, and no pathogenic 
variants were found in either of these genes. 
4.3 Functional studies  
Patch clamp data are summarized in Fig. 3A-E. HEK293 cells transfected with DNA coding for 
p.Cys375Arg channel did not show any sodium currents (n=14). Both wild type and 
p.Arg1142Gln channels conduct sodium currents. The voltage dependence of activation was 
shifted to depolarizing direction for p.Arg1142Gln channels by ~4 mV (p<0.01). This results in 
reduced peak current densities for the p.Arg1142Gln channels at voltages just above activation 
threshold. Fast inactivation properties of p.Arg1142Gln channels were also mildly attenuated: 
voltage dependence of fast inactivation was shifted in the depolarizing direction with an increase 
in the slope factor, the recovery from inactivation was accelerated and time course of 
inactivation at 0 mV was slower (all p<0.05).  The time course of closed state inactivation and 
voltage dependence of slow inactivation were unaffected.  
 
5. Discussion 
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Recessive loss-of -function mutations of Nav1.4 are rare and usually associated with a more 
severe phenotype than dominant gain of function mutations. Recessive mutations of SCN4A 
causing loss of function have been associated with rare cases of congenital myasthenic syndrome 
[3, 6].  Recessive mutations which completely abolish channel function were reported to cause a 
neonatal lethal condition, however the combination of full and partial loss of function mutations 
were associated with a classical congenital myopathy phenotype [7]. Here we describe two 
siblings with a compound heterozygous c.3425G>A (p.Arg1142Gln) and c.1123T>C 
(p.Cys375Arg) mutations in SCN4A. The p.Cys375Arg mutation is located in the extracellular 
loop between the S5 and S6 helices in domain I of NaV1.4, whereas p.Arg1142Gln is located in 
the S4 voltage sensor helix of domain III (Fig. 3F). Consistent with the reported congenital 
myopathy cases [7] we found that one of the variants, p.Cys375Arg, caused full loss of function, 
while the variant in the second allele, p.Arg1142Gln, caused partial loss of function. The loss of 
function properties of the p.Arg1142Gln are mild compared to the congenital myopathy NaV1.4 
variants described previously (four mV shift in the voltage dependence of activation). This may 
explain the comparatively mild clinical phenotype in our patients. We also describe unusual 
muscle pathology associated with mutations in SCN4A. The muscle biopsy for Sibling 2 has 
features reminiscent of necklace fibres, previously described only in centronuclear myopathies 
[8-11]. However, the muscle pathology we describe differs from the classic necklace fibres 
reported initially by Bevilacqua et.al. (2009) as electron microscopy revealed core-like structures 
encircled by morphologically normal nuclei. The pattern of clustering of the nuclei had the 
appearance of a "crown", with the central area of core-like myofibrillar disarray within the fibres 
representing a head of hair, surrounded by a crown of nuclei. Therefore, we propose designating 
them “corona” fibres to facilitate recognition of this novel neuropathologic feature. It is worth 
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noting that the core-like lesions observed in our patient are similar to those described in patients 
with RYR1 mutations, an important calcium channel also reported to cause centronuclear 
myopathy [12, 13].  
In conclusion, we report two new novel mutations in SCN4A associated with unusual muscle 
biopsy features, skeletal abnormalities and distinct pattern of involvement on muscle MRI. This 
expands the phenotypes associated with SCN4A mutations to include congenital “corona” 
myopathy.   
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Figure Legends 
 
Figure 1.  Clinical Features.  Photographs of Sibling 1 (A,B) and Sibling 2 (C, D). Both 
siblings have mild scoliosis, no joint contractures, mild hypertrophy of both calves and no 
winged scapula (B,C). Mild facial weakness, with mild ptosis, elongated facies (A,D) and 
scaphocephaly were observed  (E,F). Muscle MRI Figures and diagrams with Mercury scale for 
fat replacement (0 normal muscle, 4 complete fat replacement). (G, H) Involvement of the 
Gluteus maximus [Gmax, arrow] thighs (I,J) fatty replacement of Sartorius [S] and Adductor 
Magnus [AM], Legs (K,L) concentric involvement  of Soleus muscles [S]. (M) Family Pedigree. 
(N) Sanger confirmation of the SCN4A mutations.   
Figure 2.  Neuropathology. (A) Multiple muscle fibres showing multiple internal nuclei 
arranged in a crown-like fashion (H&E stain). (B) Lack of muscle oxidative enzyme activity in 
the center of the fibres rimmed by increased staining (SDH). (C) Gomori trichrome stain 
highlights the central cores and shows absence of ragged red fibres. (D) ATPase 9.6 staining 
revealed central areas of pallor. (E) Desmin staining  revealed desmin aggregates in some fibres 
(arrow) and positive labeling of the crown with anti desmin antibody (arrowhead) (F) Electron 
microscopic image showing multiple nuclei within a fibre rimming a core of myofibrillar 
disarray.  
Figure 3.  Functional properties of wild type and mutant channels. (A)Representative whole 
cell patch clamp current traces for wild type, p.Cys375Arg and p.Arg1142Gln channels in 
response to voltage steps ranging from -100 mV to 50 mV in 10 mV increments from holding 
voltage of –80 mV. The voltage protocol is shown in insert. The arrows point the current trace in 
response to voltage step to -20 mV. The wild type current amplitude at -20 mV is closer to the 
maximal current amplitude compared to p.Arg1142Gln channels. No currents were detected in 
cells transfected with vector coding for p.Cys375Arg. Scale bars are 0.5 ms (x-axis) and 0.5 nA 
(y-axis). (B)  Mean peak current density of wild type (solid square), p.Cys375Arg (solid circle) 
and p.Arg1142Gln (open circles) channels is plotted against the test voltage, measured using 
voltage protocol in G. Asterisks next to the p.Arg1142Gln symbols indicate the voltages at which 
the current density of the R1142Q channels was statistically significantly (Student’s t-test) lower 
for R1142Q than for wild type channels. N(WT)=15, n(p.Cys375Arg)=14, n(p.Arg1142Gln)=18. 
Dashed line indicates zero current level. (C). Voltage dependence of activation is shifted in 
depolarizing direction for p.Arg1142Gln channels compared to wild type channels. Voltage 
protocol is as in A. The conductance is plotted against the test voltage and fitted with Boltzmann 
function. The voltage at which half of the p.Arg1142Gln channels are active (-16.7±0.7 m V, 
n=18) is significantly different (p<0.01) from that of wild-type channels (-20.4±0.9 mV, n=15). 
The slope factors did not differ. Solid line shows the Boltzmann fit to mean wild type data, 
dashed line to mean p.Arg1142Gln data. (D). Voltage dependence of fast inactivation is shifted 
in depolarizing direction for p.Arg1142Gln channels compared to wild type channels. The 
voltage protocol is shown in insert. A pre-pulse voltage step of 150 ms ranging from -150 mV to 
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0 mV in 10 mV increments was followed by a step to test voltage of -10 mV. The peak current in 
response to the test voltage step is plotted against the pre-pulse voltage and fitted with 
Boltzmann function. The voltage at which half of the p.Arg1142Gln channels are inactivated (-
61.4±1.0 mV, n=18) is significantly different (p<0.05) from that of wild-type channels (-
65.2±1.0 mV, n=15). The slope factor was also slightly increased for p.Arg1142Gln channels 
(VSlope=5.7±0.2 mV) compared to the wild type channels (VSlope=5.1±0.1 mV) (p<0.05). Solid 
line shows the Boltzmann fit to mean wild type data, dashed line to mean p.Arg1142Gln data. 
(E). Table1 A-Additional biophysical parameters of the p.Arg1142Gln and wild type channels. 
The mean ± the standard error of mean are shown.  * = p ≤ 0.05, ** = p ≤ 0.01. OSI= open state 
inactivation, CSI= closed state inactivation, SI= slow inactivation. Parameters were measured 
using the voltage protocols as in Zaharieva et al. except for time course of closed state 
inactivation. This was studied by stepping the voltage to -60 mV for increasing duration of time, 
followed by a test voltage step to -10 mV. Time course of decrement of the peak current at test 
voltage was fitted with single exponential function.  (F) Location of the mutations of the 
Nav1.4channel described in this report. 
 
